Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Net Income (2016 - 2025)

Historic Net Income for Agios Pharmaceuticals (AGIO) over the last 13 years, with Q3 2025 value amounting to -$103.4 million.

  • Agios Pharmaceuticals' Net Income fell 11091.16% to -$103.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$403.0 million, marking a year-over-year decrease of 16005.72%. This contributed to the annual value of $673.7 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Net Income of -$103.4 million as of Q3 2025, which was down 11091.16% from -$112.5 million recorded in Q2 2025.
  • Agios Pharmaceuticals' Net Income's 5-year high stood at $2.0 billion during Q1 2021, with a 5-year trough of -$112.5 million in Q2 2025.
  • Its 4-year average for Net Income is $131.3 million, with a median of -$85.4 million in 2023.
  • Per our database at Business Quant, Agios Pharmaceuticals' Net Income soared by 438287.33% in 2021 and then crashed by 11091.16% in 2025.
  • Quarter analysis of 4 years shows Agios Pharmaceuticals' Net Income stood at $4.0 million in 2021, then crashed by 2524.56% to -$95.9 million in 2023, then dropped by 0.61% to -$96.5 million in 2024, then dropped by 7.16% to -$103.4 million in 2025.
  • Its Net Income stands at -$103.4 million for Q3 2025, versus -$112.5 million for Q2 2025 and -$90.5 million for Q1 2025.